{"id":"oral-melatonin-4-mg","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Drowsiness"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL45","moleculeType":"Small molecule","molecularWeight":"232.28"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Melatonin is an endogenous hormone that acts as a circadian rhythm regulator by binding to melatonin receptors in the suprachiasmatic nucleus and other tissues. At a 4 mg oral dose, it helps synchronize sleep-wake cycles and may improve sleep onset and quality. The drug also has antioxidant and anti-inflammatory properties that may contribute to its therapeutic effects.","oneSentence":"Melatonin binds to melatonin receptors (MT1 and MT2) to regulate circadian rhythm and promote sleep.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:44.557Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Insomnia or sleep disturbances"},{"name":"Circadian rhythm sleep disorders"}]},"trialDetails":[{"nctId":"NCT06404112","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2024-07-31","conditions":"Long COVID, Long COVID-19, Sleep Disturbance","enrollment":470},{"nctId":"NCT06404086","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-07-31","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":830},{"nctId":"NCT06226025","phase":"PHASE2","title":"Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder","status":"RECRUITING","sponsor":"Leslie Swanson","startDate":"2024-08-13","conditions":"Bipolar Disorder, Delayed Sleep-Wake Phase Disorder","enrollment":50},{"nctId":"NCT04335968","phase":"PHASE3","title":"Melatonin for Prevention of Postoperative Delirium After Lower Limb Fracture Surgery in Elderly Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-01-23","conditions":"Orthopedic Surgery","enrollment":357},{"nctId":"NCT06802913","phase":"EARLY_PHASE1","title":"A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study","status":"RECRUITING","sponsor":"Woolcock Institute of Medical Research","startDate":"2025-07-01","conditions":"Insomnia","enrollment":10},{"nctId":"NCT06801379","phase":"EARLY_PHASE1","title":"A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study","status":"RECRUITING","sponsor":"Woolcock Institute of Medical Research","startDate":"2025-07-01","conditions":"Insomnia","enrollment":5},{"nctId":"NCT07062757","phase":"NA","title":"Lymphatic Drainage Massage and Melatonin in Post-Orthognathic Surgery Pain and Edema","status":"ENROLLING_BY_INVITATION","sponsor":"Bezmialem Vakif University","startDate":"2025-03-30","conditions":"Dentofacial Deformities, Edema, Pain","enrollment":40},{"nctId":"NCT06872944","phase":"EARLY_PHASE1","title":"Effect of Melatonin on Postoperative Pain After Simple Nephrectomy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-03-21","conditions":"Pain Score (VAS) at 24 h Postoperatively","enrollment":40},{"nctId":"NCT05440734","phase":"NA","title":"Exogenous Melatonin in Postmenopausal Women with Insomnia","status":"TERMINATED","sponsor":"Douglas Mental Health University Institute","startDate":"2022-06-17","conditions":"Insomnia","enrollment":6},{"nctId":"NCT06777342","phase":"NA","title":"Effect of Preoperative Sleep Intervention on Postoperative Delirium in Adult Patients Undergoing Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Yan Fuxia","startDate":"2025-02-01","conditions":"Delirium - Postoperative, Sleep Problems, CABG","enrollment":1281},{"nctId":"NCT06724432","phase":"NA","title":"Analgesic and Antioxidant Effects of Melatonin in Pediatric Surgery","status":"COMPLETED","sponsor":"University of Parma","startDate":"2021-06-01","conditions":"Postoperative Pain, Oxidative Stress Response","enrollment":44},{"nctId":"NCT03438526","phase":"PHASE4","title":"The Basel BOMP-AID Randomized Trial","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-01-03","conditions":"Hypoactive Delirium","enrollment":190},{"nctId":"NCT06382610","phase":"NA","title":"Pharmacokinetics of Melatonin Administered in Oral, Lotion, and Bubble Bath Formulations","status":"COMPLETED","sponsor":"University of Redlands","startDate":"2024-05-19","conditions":"Sleep","enrollment":12},{"nctId":"NCT03688464","phase":"EARLY_PHASE1","title":"Treatment of Nighttime Pruritus in Atopic Dermatitis","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2019-02-02","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT05307770","phase":"NA","title":"Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2022-05-01","conditions":"Rapid Eye Movement Sleep Behavior Disorder, Parkinson Disease","enrollment":25},{"nctId":"NCT04474483","phase":"PHASE2","title":"Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19","status":"TERMINATED","sponsor":"State University of New York at Buffalo","startDate":"2020-11-06","conditions":"COVID-19","enrollment":8},{"nctId":"NCT05536596","phase":"PHASE2, PHASE3","title":"Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy","status":"UNKNOWN","sponsor":"Universitat Internacional de Catalunya","startDate":"2022-09-30","conditions":"Retrognathism, Prognathism, Orthognathic Surgery","enrollment":220},{"nctId":"NCT05492812","phase":"NA","title":"Sedation and Nursing Management in EEG Recording in Children","status":"COMPLETED","sponsor":"Suleyman Demirel University","startDate":"2021-01-01","conditions":"Electroencephalography, Melatonin, Chloral Hydrate","enrollment":180},{"nctId":"NCT04570254","phase":"NA","title":"Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19","status":"COMPLETED","sponsor":"Unidad Temporal COVID-19 en Centro Citibanamex","startDate":"2020-08-19","conditions":"Pneumonia, Viral, Covid19, ARDS","enrollment":110},{"nctId":"NCT04802785","phase":"PHASE2, PHASE3","title":"The Impact of Air Travel on Passenger Cognitive Functions","status":"UNKNOWN","sponsor":"Dinara Zhumanbayeva","startDate":"2021-06","conditions":"Air Travel","enrollment":50},{"nctId":"NCT03204877","phase":"PHASE1, PHASE2","title":"Acute Metabolic Effects of Melatonin Treatment","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2017-08-22","conditions":"Glucose Metabolism Disorders","enrollment":36},{"nctId":"NCT02757079","phase":"PHASE3","title":"Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2016-06-21","conditions":"Sleep Disorders, Neurodevelopmental Disorder","enrollment":99},{"nctId":"NCT03043443","phase":"PHASE2","title":"Melatonin Use for Sleep Problems in Alcohol Dependent Patients","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2017-01-25","conditions":"Alcohol-Related Disorders","enrollment":60},{"nctId":"NCT03475459","phase":"PHASE1","title":"Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2018-04-03","conditions":"Qt Interval, Variation in","enrollment":12},{"nctId":"NCT00869869","phase":"PHASE2","title":"Melatonin Supplementation to Improve Sleep in Patients With Heart Failure","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2009-03","conditions":"Heart Failure, Sleep Disorders","enrollment":""},{"nctId":"NCT00238108","phase":"PHASE2","title":"Melatonin Supplements for Improving Sleep in Individuals With Hypertension","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-10","conditions":"Sleep Disorders, Hypertension","enrollment":16},{"nctId":"NCT01114373","phase":"PHASE2","title":"Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study","status":"COMPLETED","sponsor":"Emory University","startDate":"2010-06","conditions":"Hypertension","enrollment":40},{"nctId":"NCT00625742","phase":"NA","title":"Multimodal Treatment Strategy for Cancer Cachexia","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-02","conditions":"Advanced Cancer, Cachexia","enrollment":15},{"nctId":"NCT01114360","phase":"PHASE2","title":"Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study","status":"COMPLETED","sponsor":"Emory University","startDate":"2010-03","conditions":"Hypertension","enrollment":37},{"nctId":"NCT00513357","phase":"PHASE3","title":"Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-06","conditions":"Gastrointestinal Cancer, Lung Cancer","enrollment":82},{"nctId":"NCT00506064","phase":"PHASE1","title":"Melatonin Postoperative Sleep Study in Breast Cancer Patients","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2004-02","conditions":"Breast Cancer","enrollment":4},{"nctId":"NCT01575678","phase":"PHASE2","title":"The Effect of Melatonin on Nocturnal Enuresis","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2012-01","conditions":"Nocturnal Enuresis","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["N-Acetyl-5-methoxytryptamine","Circadin","Melatonin"],"phase":"phase_3","status":"active","brandName":"Oral Melatonin (4 mg)","genericName":"Oral Melatonin (4 mg)","companyName":"Woolcock Institute of Medical Research","companyId":"woolcock-institute-of-medical-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Melatonin binds to melatonin receptors (MT1 and MT2) to regulate circadian rhythm and promote sleep. Used for Insomnia or sleep disturbances, Circadian rhythm sleep disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}